Factors such as increasing prevalence of lung cancer and chronic respiratory diseases and increasing preference for minimally invasive procedures are expected to drive the growth of the airway/lung stents market. The need for customized lung stents and the ability to print stents using current 3D printing technologies are expected to create growth opportunities for this market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890
An airway/lung stent is an endobronchial prosthesis of different materials that supports and preserves the patency of the hollow tubular airway structure.
Market Segmentation
Based on end user, the airway stent/lung stent market is segmented into hospitals and ambulatory surgical centers. the hospitals segment will dominate the airway/lung stents market. The growing number of hospitals, increasing cases of lung cancer & other chronic airway diseases treated in hospitals, growth in the healthcare sector in emerging economies, and the increasing out-of-pocket healthcare expenditure across the globe are the key factors driving the demand for airway/lung stents in hospitals.
Based on type, the airway stent/lung stent market is categorized into tracheobronchial and laryngeal stents. the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market. The large share of this segment can be attributed to the high adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases.
Regional Analysis
North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. The dominant share of North America is attributed mainly to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and the rising healthcare expenditure.
Key Market Players
Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina)
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890
Expected Revenue Growth:
[164 Pages Report] The lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%.
Boston Scientific Corporation (US) dominated the airway stent/lung stent market. Pulmonary/airway/lung stents such as Ultraflex, Dynamic, and Polyflex offered by Boston Scientific has set a benchmark in the market.
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- A further breakdown of the Rest of European airway stent/lung stent market into the Netherlands, Belgium, Switzerland, and other countries
- A further breakdown of the RoAPAC airway stent/lung stent market into South Korea, Australia, New Zealand, and other countries
- A further breakdown of the Latin American airway stent/lung stent market into Brazil, Mexico, and other countries
Company Information
- Detailed analysis and profiling of additional market players
Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32315890
